Beigene Stock In The News
BGNE Stock | USD 156.39 1.31 0.84% |
The overall news coverage of BeiGene from major news outlets shows solid bullish sentiment on 16 news articles, blog posts, and TV commentaries analyzed in the last few months. Our overall analysis of BeiGene's news coverage and content from conventional and social sources shows investors' bearish mood towards BeiGene. The specific impact of BeiGene news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of BeiGene's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using BeiGene headlines in addition to utilizing other, more conventional financial analysis modules. Check out BeiGene Backtesting and BeiGene Hype Analysis. For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.
BeiGene |
BeiGene Today Top News and Investor Outlook
BeiGene Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide BeiGene and other traded companies coverage. We help investors stay connected with BeiGene headlines for the 29th of March to make an informed investment decision based on correlating the impacts of news items on BeiGene Stock performance. Please note that trading solely based on the BeiGene hype is not for everyone as timely availability and quick action are needed to avoid losses.BeiGene stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the BeiGene earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about BeiGene that are available to investors today. That information is available publicly through BeiGene media outlets and privately through word of mouth or via BeiGene internal channels. However, regardless of the origin, that massive amount of BeiGene data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of BeiGene news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of BeiGene relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to BeiGene's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive BeiGene alpha.
BeiGene Largest EPS Surprises
Earnings surprises can significantly impact BeiGene's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2017-03-22 | 2016-12-31 | -0.89 | -1.05 | -0.16 | 17 | ||
2016-11-10 | 2016-09-30 | -0.82 | -1.08 | -0.26 | 31 | ||
2017-08-09 | 2017-06-30 | -1.25 | -1.52 | -0.27 | 21 | ||
2018-05-09 | 2018-03-31 | -1.7 | -2.03 | -0.33 | 19 | ||
2016-05-11 | 2016-03-31 | -0.63 | -0.97 | -0.34 | 53 | ||
2017-05-10 | 2017-03-31 | -0.92 | -1.27 | -0.35 | 38 |
BeiGene Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to BeiGene Stock. Current markets are strongly bullish. About 72% of major world exchanges and indexes are currently up. See today's market update for more information.27th of March 2024
Shareholders in BeiGene have lost 54, as stock drops 8.5 percent this past week at finance.yahoo.com
26th of March 2024
Disposition of 4099 shares by Xiaodong Wang of BeiGene at 260.305 subject to Rule 16b-3 at Xiaodong Wang
25th of March 2024
Disposition of 111 shares by Wang Lai of BeiGene at 225.2721 subject to Rule 16b-3 at Wang Lai
19th of March 2024
Disposition of 14677 shares by Ball Titus B. of BeiGene at 15.97 subject to Rule 16b-3 at Ball Titus B.
15th of March 2024
BeiGene recibe la aprobacin de la FDA para TEVIMBRA para el tratamiento del carcinoma esof... at businesswire.com
14th of March 2024
Pi Health Raises Over 30M in Series A to Revolutionize Cancer Care and Clinical Trials at businesswire.com
13th of March 2024
As primeiras doses de BRUKINSA fornecidas a pacientes com leucemia linfoctica crnica em pa... at businesswire.com
12th of March 2024
Disposition of 200 shares by John Oyler of BeiGene at 169.05 subject to Rule 16b-3 at John Oyler
11th of March 2024
Disposition of 82020 shares by Donald Glazer of BeiGene subject to Rule 16b-3 at Donald Glazer
6th of March 2024
BeiGene to Present Clinical and Preclinical Data from Broad Portfolio and Pipeline at AACR... at businesswire.com
27th of February 2024
BeiGene erhlt positives CHMP-Gutachten fr Tislelizumab zur Behandlung von nicht-kleinzelli... at businesswire.com
6th of February 2024
JPMorgan raises BeiGene rating to Overweight, sets 185 target at investing.com
BeiGene Investors Sentiment
The influence of BeiGene's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in BeiGene. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to BeiGene's public news can be used to forecast risks associated with an investment in BeiGene. The trend in average sentiment can be used to explain how an investor holding BeiGene can time the market purely based on public headlines and social activities around BeiGene. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
BeiGene's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for BeiGene's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average BeiGene's news discussions. The higher the estimated score, the more favorable is the investor's outlook on BeiGene.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BeiGene in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BeiGene's short interest history, or implied volatility extrapolated from BeiGene options trading.
Check out BeiGene Backtesting and BeiGene Hype Analysis. For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for BeiGene Stock analysis
When running BeiGene's price analysis, check to measure BeiGene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BeiGene is operating at the current time. Most of BeiGene's value examination focuses on studying past and present price action to predict the probability of BeiGene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BeiGene's price. Additionally, you may evaluate how the addition of BeiGene to your portfolios can decrease your overall portfolio volatility.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
CEOs Directory Screen CEOs from public companies around the world | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Is BeiGene's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BeiGene. If investors know BeiGene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BeiGene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.45) | Revenue Per Share 23.554 | Quarterly Revenue Growth 0.669 | Return On Assets (0.12) | Return On Equity (0.22) |
The market value of BeiGene is measured differently than its book value, which is the value of BeiGene that is recorded on the company's balance sheet. Investors also form their own opinion of BeiGene's value that differs from its market value or its book value, called intrinsic value, which is BeiGene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BeiGene's market value can be influenced by many factors that don't directly affect BeiGene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BeiGene's value and its price as these two are different measures arrived at by different means. Investors typically determine if BeiGene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BeiGene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.